Lunai Bioworks (NASDAQ: LNAI), an AI-based pharmaceutical discovery company that recently announced its first pharma ...

So far five companies have agreed to the terms. They are Pfizer, Eli ​Lilly, AstraZeneca, Novo Nordisk and EMD Serono, which ...

The tragedy of rare disease is not only measured in lives lost—it’s also measured in lives that could have been saved, if only abandoned discoveries had been given another chance.

Global Research Antibodies and Reagents Market OverviewThe global research antibodies and reagents market is expected to expand at a CAGR of 7% between 2025 and 2030, driven by the rising need for ...

The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with ...

Merck (MRK) just cleared an important clinical hurdle, reporting strong Phase 3 KEYNOTE B15 results showing that KEYTRUDA ...

Merck's oral PCSK inhibitor for cholesterol, enlicitide, and its cancer antibody-drug conjugate sacituzumab tirumotecan ...

Merck says Keytruda plus Padcev improved survival and response rates versus chemotherapy in a Phase 3 muscle-invasive bladder ...

Merck & Co., Inc. (NYSE:MRK) is included among the 12 Best Dogs of the Dow to Invest in. On December 15, BofA raised its price target on Merck & Co., Inc. (NYSE:MRK) to $120 from $105 and kept a Buy ...

Merck, Pfizer and Astellas, which in August reported similar results from a Phase 3 study of the combination in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based ...

Pfizer (PFE) stock is in focus as the firm with Astellas (ALPMF) post a Phase 3 trial win for Padcev cancer drug when used ...

TAIPEI (Taiwan News) — Germany-based Merck has opened a new semiconductor materials facility in Kaohsiung, a move analysts ...